We envision a world where no one dies of tuberculosis. However, this cannot be achieved without improved, faster-acting, and affordable tuberculosis drug regimens that are available to all who need them. These new cures can bring renewed health, hope, and prosperity to millions. 

Since our inception in 2000, TB Alliance has led the global search for and development of new TB regimens, catalyzing the field and convening cross-sector partnerships to forge the progress that is urgently needed for better TB treatments.

Health Care

Tobacco

TB Alliance

Mel Spigelman

Nader Fotouhi

Maria Beumont

Majda Benhayoun

Kathleen Schostack

Sandeep Juneja

Colleen Pero

Angela Vanderploeg

Pietro Turilli

Leadership Team

Scientific and Research Team

Clinical Operations Team

Administrative Team

External Affairs and Communication

Finance Team

Program and Alliance Management

Teams at TB Alliance